CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 20, 2002--Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by The Biotechnology Industry Organization on Thursday, February 21, 2002 at 8:10am ET. The presentation will be webcast live and may be accessed under the investor relations tab at www.alkermes.com.
Richard Pops, Chief Executive Officer of Alkermes, Inc., will present an overview of the company at 8:10am ET on Thursday, February 21, 2002, from The Waldorf Astoria Hotel in New York.
Alkermes is a leader in the development of products based on sophisticated drug delivery technologies. We have several areas of focus, including (i) controlled, sustained-release of injectable drugs lasting several days to several weeks, using our ProLease(R) and Medisorb(R) technologies and (ii) the development of pharmaceutical products based on our proprietary AIR(TM) pulmonary technology. In addition to our Cambridge, Massachusetts, headquarters, research and manufacturing facilities, Alkermes operates research and manufacturing facilities in Ohio and a medical affairs office in Cambridge, England.
CONTACT: Alkermes, Inc.
Investor Relations
Rebecca Peterson
(617) 583-6378